Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Friday June 10th, CCBIO and the Holberg Prize hosted a Special Seminar with the 2022 Holberg Laureate, Sheila Jasanoff (Harvard University) in conversation with Stephen Hilgartner (Cornell University). The seminar was called “Can science make sense of life?”, referring to Jasanoff’s recent and eponymous book. This was the first time the Faculty of Medicine had the opportunity to welcome a Holberg... Read more
The 10th CCBIO Annual Symposium took place at Solstrand Hotel May 10 and 11, 2022, finally as an onsite event, attracting about 200 onsite and 60 online, as the symposium was offered as a hybrid solution.
Researcher and co-founder of the biotech-company Moderna, Robert S. Langer, has met a lot of skepticism and rejection in his career. He explains the road to success with being stubborn, having courage to think big and to have good role-models.
This question is central to the research of the 2022 Holberg Prize winner, Sheila Jasanoff, who has a long-standing collaboration with University of Bergen researchers.
The PhD level course on Health Innovation, CCBIONEUR912, was kicked off November 8-9, 2021, at the facilities of the new medical incubator EITRI. CCBIONEUR912 is joining the course SDG900 as the second innovation course offering at UiB on the PhD level. It is the first PhD course on health innovation and thus an invaluable offering for medical researchers at the beginning of their research... Read more
The Trond Mohn Foundation has now announced that Carina Strell will be one of three candidates at the University of Bergen (UiB) to be awarded with a TMS starting grant, for her project Understanding Early Breast Cancer Evolution in Space and Time (EvoMaps). Strell has a long-term collaboration with the Lars A. Akslen group at CCBIO, and her project will be embedded at CCBIO.
November 9, Professor Robert S. Langer, Massachusetts Institute of Technology, presented the Falch Lecture entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Through a live streaming from MIT, the around 200 people in Store Auditorium enjoyed a truly inspirational talk, motivating them to pursue their ideas and keep asking the fundamental questions.
November 9, Professor Robert S. Langer, Massachusetts Institute of Technology, will present the Falch Lecture at a live streaming from MIT in Store Auditorium entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Dr. Langer has been called "The Edison of Medicine", and he has an exceptional track record in science and innovation.
On October 20, CCBIO hosted a Celebration Seminar to celebrate the awarding of the King Olav V’s Prize for Cancer Research 2021 to Professor Bjørn Tore Gjertsen. Leaders from the university and the hospital as well as close colleagues gave highly praising speeches and scientific talks.
The Norwegian Cancer Society announced September 2nd that this year’s King Olav V's Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen. The award amounts to 1 million NOK, is considered as a great honor in the Norwegian research communities and goes to the very best in the entire spectrum of Norwegian cancer research.
Dana Costea is this year’s receiver of the Pindborg Prize, an annual award issued by The Scandinavian Fellowship of Oral Pathology and Oral Medicine (SFOPOM), in memory of the late Professor Jens J. Pindborg, internationally renowned dentist and pathologist.
A broad range of renowned international cancer scientists gave talks at the 2021 CCBIO Annual Symposium, which for the very first time was held as a fully online event.
CCBIO initiated its research school – CCBIO Research School for Cancer Studies (RSCS) – very early on, and the RSCS has since the startup in 2014 undergone a steady progress and expansion of the course portfolio. Now that CCBIO’s parent department the Department of Clinical Medicine has been assigned an FKB center (Centre for Clinical Treatment Research) – Neuro-SysMed – CCBIO is happy to be able... Read more
CCBIO’s PhD course CCBIO905 Methods in Cancer Biomarker Research was for the first time run on a digital platform October 27-29, 2020. The course was well attended, 80 participants followed selected lectures for non-ECTS participation, and 34 students completed the course with ECTS credits. The participants signed in from 15 different universities and 8 different countries with the majority of... Read more
In collaboration with the Vascular Biology Program (VBP), Boston Children’s Hospital, CCBIO recently completed the second CCBIO INTPART long course CCBIO907. This year, the course was given in digital format, and it was well visited by local students and researchers, participants from other institutions all over Norway, and also from Finland, Sweden and Denmark, in addition to some from other... Read more
CCBIO Postdoc Katrin Kleinmanns, together with CCBIO PhD Katharina Bischoff and Researcher Vibeke Fosse, recently published 2 articles in EBioMedicine. Their work describing CD24-targeted near-infrared (NIR) fluorescence imaging in patient-derived xenograft (PDX) models of high-grade serous ovarian carcinoma (HGSOC), confirms an improvement of cytoreduction of ovarian cancer in PDX orthotopic... Read more
The pandemic situation and lockdown of campus has forced CCBIO to think new in order to fulfill the goals for the CCBIO Research School for Cancer Studies. On fairly short notice, the 2 planned spring courses were rescheduled to new dates and organized through digital platforms. Despite of limited time to get the word out, registration for both courses soon had to be closed, due to great interest... Read more
The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.

Pages